Carisma Therapeutics Inc (CARM)

Currency in USD
0.388
-0.006(-1.52%)
Closed·
After Hours
0.380-0.008(-2.04%)
·
CARM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.3600.390
52 wk Range
0.1421.270
Key Statistics
Prev. Close
0.394
Open
0.39
Day's Range
0.36-0.39
52 wk Range
0.142-1.27
Volume
539.73K
Average Volume (3m)
14.37M
1-Year Change
-64.07%
Book Value / Share
-0.88
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Carisma Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Carisma Therapeutics Inc Company Profile

Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidate includes CT-2401, which is in preclinical trail for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanced mesothelin-positive solid tumors, including pancreatic cancer, ovarian cancer, lung cancer, mesothelioma, and others. In addition, it develops in vivo CAR-M cell therapy to treat solid tumors, including hepatocellular carcinoma. Carisma Therapeutics, Inc. has collaboration and license agreement with ModernaTX, Inc. to address oncology gene therapies. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. Carisma Therapeutics, Inc. was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1.000
(+157.73% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.22 / -0.51
Revenue / Forecast
3.73M / --
EPS Revisions
Last 90 days

CARM Income Statement

People Also Watch

1.23
KLTO
-3.15%
0.060
NCNA
+11.11%
3.08
RBNE
-2.84%
8.150
HSDT
-1.45%
0.069
HCTI
+25.78%

FAQ

What Stock Exchange Does Carisma Therapeutics Trade On?

Carisma Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Carisma Therapeutics?

The stock symbol for Carisma Therapeutics is "CARM."

What Is the Carisma Therapeutics Market Cap?

As of today, Carisma Therapeutics market cap is 16.21M.

What Is Carisma Therapeutics's Earnings Per Share (TTM)?

The Carisma Therapeutics EPS (TTM) is -1.22.

From a Technical Analysis Perspective, Is CARM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Carisma Therapeutics Stock Split?

Carisma Therapeutics has split 1 times.

How Many Employees Does Carisma Therapeutics Have?

Carisma Therapeutics has 46 employees.

What is the current trading status of Carisma Therapeutics (CARM)?

As of 26 Jul 2025, Carisma Therapeutics (CARM) is trading at a price of 0.39, with a previous close of 0.39. The stock has fluctuated within a day range of 0.36 to 0.39, while its 52-week range spans from 0.14 to 1.27.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.